title: Development and use of a polarized equine upper respiratory tract mucosal explant system to study the early phase of pathogenesis of a European strain of equine arteritis virus.
abstract: The upper respiratory tract mucosa represents the first line of defense, which has to be overcome by pathogens before invading the host. Considering the economic and ethical aspects involved in using experimental animals for pathogenesis studies, respiratory mucosal explants, in which the tissue's three-dimensional architecture is preserved, may be ideal alternatives. Different respiratory mucosal explant cultures have been developed. However, none of them could be inoculated with pathogens solely at the epithelium side. In the present study, equine nasal and nasopharyngeal explants were embedded in agarose (3%), leaving the epithelium side exposed to allow apical inoculation. Morphometric analysis did not show degenerative changes during 72 h of cultivation. The number of apoptotic cells in the mucosa slightly increased over time. After validation, the system was used for apical infection with a European strain (08P178) of equine arteritis virus (EAV) (107.6TCID50/mL per explant). Impermeability of agarose to virus particles was demonstrated by the absence of labeled microspheres (40 nm) and a lack of EAV-antigens in RK13 cells seeded underneath the agarose layer in which inoculated explants were embedded. At 72 hpi, 27% of the EAV-positive cells were CD172a+ and 19% were CD3+ in nasal explants and 45% of the EAV-positive cells were CD172a+ and 15% were CD3+ in nasopharyngeal explants. Only a small percentage of EAV-positive cells were IgM+. This study validates the usefulness of a polarized mucosal explant system and shows that CD172a+ myeloid cells and CD3+ T lymphocytes represent important EAV-target cells in the respiratory mucosa.
authors.affiliation: Laboratory of Virology, Department of Virology, Parasitology and Immunology, Faculty of Veterinary Medicine, Ghent University, Merelbeke B-9820, Belgium. hans.nauwynck@ugent.be.
authors.forename: Sabrina
authors.initials: S
authors.lastname: Vairo
authors.forename: Wim
authors.initials: W
authors.lastname: Van den Broeck
authors.forename: Herman
authors.initials: H
authors.lastname: Favoreel
authors.forename: Alessandra
authors.initials: A
authors.lastname: Scagliarini
authors.forename: Hans
authors.initials: H
authors.lastname: Nauwynck
mesh_terms: D000818:Animals; D018174:Arterivirus Infections / Q000662:veterinary* / Q000821:virology; D002470:Cell Survival; D007240:Equartevirus / Q000502:physiology*; D005260:Female; D006734:Horse Diseases / Q000821:virology*; D006736:Horses; D066298:In Vitro Techniques; D008297:Male; D022423:Myeloid Cells / Q000166:cytology / Q000821:virology; D009297:Nasal Mucosa / Q000821:virology*; D012685:Sepharose / Q000737:chemistry; D013601:T-Lymphocytes / Q000166:cytology / Q000821:virology; D014764:Viral Proteins / Q000235:genetics / Q000502:physiology; D014779:Virus Replication
chemical_list: D014764:Viral Proteins; D012685:Sepharose
references.citation: Vet J. 2009 Sep;181(3):280-7
references.pmid: 18539059
references.citation: J Virol. 2011 Dec;85(24):13174-84
references.pmid: 21994447
references.citation: Blood. 1997 Aug 15;90(4):1379-86
references.pmid: 9269754
references.citation: J Exp Med. 1997 Jun 16;185(12):2133-41
references.pmid: 9182685
references.citation: J Gen Virol. 2003 Oct;84(Pt 10):2745-2753
references.pmid: 13679609
references.citation: J Am Vet Med Assoc. 1998 Aug 1;213(3):385-90
references.pmid: 9702229
references.citation: Virology. 1964 Sep;24:13-8
references.pmid: 14208896
references.citation: Vet Res. 2011 Feb 15;42:33
references.pmid: 21324115
references.citation: Trends Microbiol. 2012 Mar;20(3):147-55
references.pmid: 22300759
references.citation: Vet Microbiol. 2012 Jun 15;157(3-4):333-44
references.pmid: 22306037
references.citation: Lab Invest. 1998 Apr;78(4):435-51
references.pmid: 9564888
references.citation: Physiol Rev. 2002 Jan;82(1):97-130
references.pmid: 11773610
references.citation: Nature. 1998 Mar 19;392(6673):245-52
references.pmid: 9521319
references.citation: J Aerosol Med. 2000 Winter;13(4):361-7
references.pmid: 11262442
references.citation: J Virol Methods. 2007 Jun;142(1-2):105-12
references.pmid: 17324473
references.citation: J Virol. 2010 May;84(10):4898-911
references.pmid: 20219931
references.citation: Vet Q. 2002 Jun;24(2):58-78
references.pmid: 12095082
references.citation: J Exp Med. 1991 Jun 1;173(6):1345-56
references.pmid: 2033368
references.citation: Clin Exp Allergy. 1989 Nov;19(6):597-601
references.pmid: 2688847
references.citation: Clin Microbiol Rev. 2003 Jul;16(3):463-96
references.pmid: 12857778
references.citation: Proc Natl Acad Sci U S A. 1998 Mar 31;95(7):3937-42
references.pmid: 9520471
references.citation: Vet Pathol. 2000 Jul;37(4):287-96
references.pmid: 10896389
references.citation: Infect Immun. 2006 Dec;74(12):6907-19
references.pmid: 17015455